Skip to content

SI-BONE, Inc. SIBN International — Revenue

Similar metrics at other companies

Axogen logo
AXGNInternational — Revenue
$1.33M+84.9%
Inspire Medical Systems logo
INSPInternational — Revenue
$8.98M+16.5%
AngioDynamics logo
ANGOInternational — Revenue
$10.38M-20.8%
Dropbox logo
DBXInternational — Revenue
$277.9M+3.6%
MGN
MGNIInternational — Revenue
$41.08M+5.4%
iRadimed logo
IRMDInternational — Total Revenue
$3.95M+11.1%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s international — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s international — revenue?
SI-BONE, Inc. (SIBN) reported international — revenue of $3.29M in Q1 2026.
How has SI-BONE, Inc.'s international — revenue changed year-over-year?
SI-BONE, Inc.'s international — revenue increased by 33.9% year-over-year, from $2.45M to $3.29M.
What is the long-term trend for SI-BONE, Inc.'s international — revenue?
Over 4 years (2021 to 2025), SI-BONE, Inc.'s international — revenue has grown at a 7.4% compound annual growth rate (CAGR), from $7.41M to $9.85M.
What does international — revenue mean?
This metric represents the total gross sales generated from products sold outside of the company's primary domestic market. It serves as a key indicator of the company's global commercial footprint and the successful adoption of its medical device portfolio in international healthcare systems. Growth in this segment reflects the effectiveness of international distribution networks and the company's ability to navigate diverse regulatory and reimbursement environments.